Cargando…

YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner

BACKGROUND: The YTH domain family protein 3 (YTHDF3) is an important N6-methyladenosine (m(6)A) reader which is involved in multiple cancers. However, the biological role and mechanisms of action for YTHDF3 in triple-negative breast cancer (TNBC) remains to be elucidated. METHODS: The expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yuxiang, Jin, Xuan, Nie, Qian, Chen, Minyan, Guo, Wenhui, Chen, Lili, Li, Yan, Chen, Xiaobin, Zhang, Wenzhe, Chen, Hanxi, Jiang, Meichen, Xiao, Han, Zhang, Jie, Fu, Fangmeng, Wang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848410/ https://www.ncbi.nlm.nih.gov/pubmed/35282088 http://dx.doi.org/10.21037/atm-21-6857

Ejemplares similares

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis
por: Chen, Lili, et al.
Publicado: (2023)

HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022)

Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
por: Liu, Xiangxiang, et al.
Publicado: (2022)

PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner
por: Sun, Sheng, et al.
Publicado: (2022)

High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
por: Zhang, Wenzhe, et al.
Publicado: (2023)

Anti-tumor immunity controlled through mRNA m(6)A and YTHDF1 in dendritic cells
por: Han, Dali, et al.
Publicado: (2019)

Ythdf2-mediated m(6)A mRNA clearance modulates neural development in mice
por: Li, Miaomiao, et al.
Publicado: (2018)

The m(6)A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m(6)A-Dependent Manner
por: Chen, Xiao-Yu, et al.
Publicado: (2021)

LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m(6)A‐YTHDF2‐dependent manner
por: Fang, Yuan, et al.
Publicado: (2023)

YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy
por: Xu, Hongfei, et al.
Publicado: (2021)

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
por: Chen, Hengyu, et al.
Publicado: (2022)

YTHDF2 facilitates aggresome formation via UPF1 in an m(6)A-independent manner
por: Hwang, Hyun Jung, et al.
Publicado: (2023)

m(6)A binding protein YTHDF2 in cancer
por: Chen, Xiaomin, et al.
Publicado: (2022)

METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner
por: Xu, Qiong-Cong, et al.
Publicado: (2022)

Associations of Two Common Genetic Variants with Breast Cancer Risk in a Chinese Population: A Stratified Interaction Analysis
por: Lin, Yuxiang, et al.
Publicado: (2014)

Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients
por: Li, Yan, et al.
Publicado: (2022)

SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m(6)A-modified mRNAs
por: Hou, Guofang, et al.
Publicado: (2021)

ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1
por: Han, Zhenbo, et al.
Publicado: (2021)

METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m(6)A-YTHDF2-dependent manner
por: Li, Jiaren, et al.
Publicado: (2022)

METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer
por: Zhan, Lei, et al.
Publicado: (2023)

The m(6)A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m(6)A dependent manner
por: Ke, Meng-Yun, et al.
Publicado: (2023)

The m(6)A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m(6)A-Dependent Manner
por: Diao, Hongtao, et al.
Publicado: (2023)

FTO-dependent m(6)A regulates muscle fiber remodeling in an NFATC1–YTHDF2 dependent manner
por: Wang, Wengang, et al.
Publicado: (2023)

YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation
por: Huang, Chen‐Song, et al.
Publicado: (2022)

METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B‐cell lymphoma cells
por: Feng, Lili, et al.
Publicado: (2023)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m(6)A/mRNA pathway
por: Huang, Tao, et al.
Publicado: (2020)

The mRNA m(6)A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
por: Mapperley, Christopher, et al.
Publicado: (2020)

Autophagy induction promoted by m(6)A reader YTHDF3 through translation upregulation of FOXO3 mRNA
por: Hao, WeiChao, et al.
Publicado: (2022)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

FTO promotes innate immunity by controlling NOD1 expression via m(6)A-YTHDF2 manner in teleost
por: Geng, Shang, et al.
Publicado: (2022)

RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m(6)A-YTHDF2-dependent manner
por: Tan, Zhen, et al.
Publicado: (2022)

FTO Regulated Intramuscular Fat by Targeting APMAP Gene via an m(6)A-YTHDF2-dependent Manner in Rex Rabbits
por: Luo, Gang, et al.
Publicado: (2023)

m(6)A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner
por: Wu, Ruifan, et al.
Publicado: (2019)

Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancer
por: Zhang, Jiantang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ejido4a3u3snp55h7ka2i6d8h0